Advances in Pancreatic Cancer: Expert Insights to Guide Clinical Practice

In this expert commentary, contemporary therapy for patients with resectable and advanced pancreatic cancer are discussed, with a focus on neoadjuvant and adjuvant therapy strategies and targeted therapies for cancers with actionable mutations.

Dan Laheru, MD Released: February 5, 2021

Download this concise slideset for expert perspectives on first-line systemic therapy considerations for patients with advanced pancreatic cancer.

Andrew H. Ko, MD Released: February 17, 2021

Download this concise slideset for expert perspectives on second-line systemic therapy considerations for patients with advanced pancreatic cancer.

Andrew H. Ko, MD Released: February 19, 2021

This brief activity provides expert insights into the selection of first-line systemic therapy for patients with advanced pancreatic cancer based on best available evidence.

Andrew H. Ko, MD
Program Director Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 17, 2021 Expired: February 16, 2022

This short activity provides expert insights into selection of second-line systemic therapy for patients with advanced pancreatic cancer.

Andrew H. Ko, MD
Program Director Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 19, 2021 Expired: February 18, 2022